Researchers launch phase 2 trial to test swallowing therapy for people with early Parkinson’s

Swallowing difficulties, or dysphagia, affect up to 80% of people with Parkinson’s disease and can lead to serious complications, including malnutrition, aspiration and reduced quality of life.